REFINE YOUR SEARCH
Type of document
|Date||Ref.||Title||Section||Type||Download||Info||Summary||Related Documents||Translated versions|
|19/12/2018||ESMA35-43-1328||Brexit Statement- information to clients||Brexit, MiFID - Investor Protection||Statement||PDF
|28/06/2017||ESMA35-36-885||Product Intervention- General Statement||Innovation and Products, MiFID - Investor Protection||Statement||PDF
This statement provides an update on the European Securities and Markets Authority’s (ESMA) work in relation to the sale of contracts for differences (CFDs), binary options and other speculative products to retail investors.
ESMA has been concerned about the provision of speculative products such as CFDs, rolling spot forex and binary options to retail investors for a considerable period of time and has conducted ongoing monitoring and supervisory convergence work in this area. In this context, ESMA has previously published a number of Q&As on CFDs and other speculative products to foster supervisory convergence, having established a CFD Task Force in July 2015, and also issued a further investor warning on the sale of CFDs, binary options and other speculative products in July 2016.
However, ESMA remains concerned that these supervisory convergence tools may not be sufficiently effective to ensure that the risks to consumer protection are sufficiently controlled or reduced. ESMA is therefore discussing the possible use of its product intervention powers under Article 40 of MiFIR to address investor protection risks in relation to CFDs, rolling spot forex and binary options.
ESMA is in the process of discussing the possible use of its product intervention powers under Article 40 of MiFIR, the possible content of any such measures, and how they could be applied. However, ESMA can confirm that the measures being discussed for (i) CFDs and rolling spot forex and (ii) binary options include proposals that take into account a number of measures that have been adopted or publicly consulted on by EU National Competent Authorities. These measures include leverage limits, guaranteed limits on client losses, and / or restrictions on the marketing and distribution of these products.
In accordance with Article 40 of MiFIR, any intervention measures must be approved by the ESMA Board of Supervisors and can only come into effect from 3 January 2018 at the earliest.
 ESMA/2016/1166 Warning about CFDs, binary options and other speculative products published 25 July 2016
|05/06/2020||ESMA35-36-1946||Final Report Guidelines on certain aspects of the MiFID II compliance function requirements||Guidelines and Technical standards, MiFID - Investor Protection||Final Report||PDF
|31/03/2020||ESMA35-36-1919||Clarification of issues related to the publication of reports by execution venues and firms as required under RTS 27 and 28||COVID-19, MiFID - Investor Protection||Statement||PDF
|12/07/2019||ESMA35-36-1743||Statement Product Intervention||MiFID - Investor Protection||Statement||PDF
|19/07/2019||ESMA34-49-168||Final report on MMF reporting||Fund Management||Final Report||PDF
|17/11/2017||ESMA34-49-103||Technical advice, draft implementing technical standards and guidelines under the MMF Regulation||Fund Management||Final Report||PDF
|10/12/2019||ESMA34-46-91||Final report- Draft RTS under Article 25 of the ELTIF Regulation||Fund Management||Final Report||PDF
|09/04/2020||ESMA34-45-896||Actions to mitigate the impact of COVID-19 on the deadlines for the publication of periodic reports by fund managers||COVID-19, Fund Management||Statement||PDF
|03/05/2019||ESMA34-45-688||Final report on integrating sustainability risks and factors in the UCITS Directive and the AIFMD||Fund Management, Sustainable finance||Final Report||PDF
|03/04/2020||ESMA34-39-968||Final report- Guidelines on performance fees in UCITS and certain types of AIFs||Fund Management, Guidelines and Technical standards||Final Report||PDF
|02/09/2019||ESMA34-39-882||Final Report_Guidelines on LST in UCITS and AIFs||Fund Management||Final Report||PDF
|09/07/2020||ESMA34-39-109||Public statement on external support within the meaning of Article 35 of the MMF Regulation||COVID-19, Fund Management||Statement||PDF
|18/07/2019||ESMA33-9-320||Final Report Guidelines on Disclosure Requirements Applicable to Credit Rating Agencies||Credit Rating Agencies||Final Report||PDF
|18/07/2018||ESMA33-9-246||Final report on Supplementary Guidelines on Endorsement||Credit Rating Agencies||Final Report||PDF
|17/11/2017||ESMA33-9-207||Technical Advice on CRA Regulatory Equivalence- CRA 3 Update||Credit Rating Agencies||Final Report||PDF
|17/11/2017||ESMA33-9-205||Final Report on the application of the CRA endorsement regime||Credit Rating Agencies||Final Report||PDF
|03/05/2017||ESMA33-9-174||Opening Statement for ECON Scrutiny Hearing on CRA Regulation||Credit Rating Agencies||Statement||PDF
|15/03/2019||ESMA33-5-735||ESMA statement on the endorsement of UK credit ratings in case of a no-deal Brexit||Brexit, Credit Rating Agencies||Statement||PDF
|20/05/2020||ESMA32-63-972||Implications of the COVID-19 outbreak on the half-yearly financial reports||Corporate Disclosure, COVID-19||Statement||PDF